Hello Patient vs Hippocratic AI
If your failure mode is buying the most autonomous voice agent without matching autonomy to what the calls actually do, this pair is the clearest lesson in the lane. They do different jobs and disclose their guardrails very differently. Hello Patient, founded in 2024, automates the front office and pushes for a 100 percent answer rate, but it does not publish the escalation path when a caller raises a clinical concern mid conversation. Hippocratic AI runs non diagnostic clinical outreach and treats that boundary as the product: agents are barred from diagnosis and prescribing, the Polaris constellation can end a non compliant call, every script is tested by thousands of nurses and physicians, and it carries the strongest security and oversight posture in this index. More autonomy on administrative calls is one thing. On clinical outreach, the architecture that constrains the agent is the point.
- The right fit for administrative front office coverage: inbound and outbound calls, booking, intake, insurance, refills, and billing outreach, with practices reported eliminating unanswered calls, on tasks that are administrative rather than clinical.
- Forthcoming about its build, stating plainly it fine tunes existing models rather than claiming its own, naming its voice partner, and publishing SOC 2 Type 2 and HIPAA on its main site.
- Broad across outpatient settings and quick to deploy, a fit for a multi location group that wants front desk coverage rather than clinical outreach.
- Built for clinical outreach with the guardrails to match: agents barred from diagnosis and prescribing, a constellation of safety, privacy, and medication models that can end a non compliant conversation, and a certification pipeline of simulated calls tested by thousands of nurses and physicians.
- The strongest security and oversight posture in the index: SOC 2 Type 2 plus HITRUST e1 across the full agentic platform, both named and dated, a named CISO, and a published safety score, against a competitor that publishes no escalation threshold at all.
- Transparent and enumerated: a published 9 dollars per agent hour, more than 300 prebuilt agents across 25 specialties, and published research on the Polaris architecture.
Side-by-Side
| Axis | H Hello Patient |
H Hippocratic AI |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | — | |
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | — | |
| Deployment Model and Data Residency | — | |
| Commercial Transparency | ||
| Setting and Specialty Coverage |
The two solve different problems, so this is a scope comparison, not a head to head. Hello Patient, founded in 2024, is graded C on oversight for pairing a 100 percent answer target with an unpublished escalation path, and has no longitudinal evidence. Hippocratic's operational scale and safety research are substantive, but its clinical outcome claims such as a 30 percent readmission reduction are vendor reported without methodology or comparison groups, and its governance grade is held at B for the absence of a published bias evaluation. Neither is an FDA regulated product; both run patient outreach subject to TCPA consent rules. Hippocratic publishes a per agent hour rate while Hello Patient publishes no pricing. Voice accuracy varies across accent and dialect, which neither quantifies, and which weighs more where the calls are clinical.